Stock 4519 CHUGAI PHARMACEUTICAL CO., LTD
Add to a list
To use this feature you must be a member
Log inSign up

Company Chugai Pharmaceutical Co., Ltd

Equities

4519

JP3519400000

Pharmaceuticals

Market Closed - Japan Exchange
Other stock markets
 02:00:00 2024-04-25 am EDT 		5-day change 1st Jan Change
4,860 JPY -5.65% Intraday chart for Chugai Pharmaceutical Co., Ltd -4.05% -9.02%
07:18am Chugai Pharmaceutical's Parent Roche Logs Lower Q1 Sales; Stock Falls 5% MT
Apr. 24 Chugai Pharmaceutical's Profit Slightly Up in Q1 MT

Business Summary

Chugai Pharmaceutical Co. Ltd specializes in the research, development, manufacturing and marketing of drugs especially for cancers (40.8% of net sales), bones and joints diseases treatment (18.4%), and kidney diseases (5.9%).

Net sales are distributed geographically as follows: Japan (74,3%), Switzerland (22,8%) and other (2,9%).

Number of employees: 7,604

Sales per Business

JPY in Million2022Weight2023Weight Delta
Pharmaceuticals
87.7 %
1,039,247 82.5 % 974,493 87.7 % -6.23%
Other
12.3 %
91,915 7.3 % 136,874 12.3 % +48.91%

Sales per region

JPY in Million2022Weight2023Weight Delta
Japan
50.3 %
657,273 52.2 % 559,233 50.3 % -14.92%
Switzerland
46.1 %
482,736 38.3 % 511,880 46.1 % +6.04%
Overseas
3.6 %
119,936 9.5 % 40,253 3.6 % -66.44%

Managers

Managers TitleAgeSince
Osamu Okuda CEO
 Chief Executive Officer 61 87-03-31
Junichi Nezu CTO
 Chief Tech/Sci/R&D Officer - -
Hisafumi Okabe CTO
 Chief Tech/Sci/R&D Officer - -
Motoo Ueno BRD
 Director/Board Member 66 84-03-31
Yoko Kitagawa IRC
 Investor Relations Contact - -
Keiji Kono IRO
 Public Communications Contact - -
Yoshiaki Ohhashi PRN
 Corporate Officer/Principal - -
Yoshiyuki Yano HRO
 Human Resources Officer - -
Shinji Hidaka SAM
 Sales & Marketing - -
Atsushi Sato AUD
 Comptroller/Controller/Auditor 65 81-03-31

Members of the board

Members of the board TitleAgeSince
Masayuki Oku BRD
 Director/Board Member 79 15-02-28
Motoo Ueno BRD
 Director/Board Member 66 84-03-31
James H. Sabry BRD
 Director/Board Member 65 19-02-28
Christoph Franz BRD
 Director/Board Member 63 17-02-28
Yoichiro Ichimaru BRD
 Director/Board Member 75 17-02-28
William Anderson BRD
 Director/Board Member 57 19-02-28
Osamu Okuda CEO
 Chief Executive Officer 61 87-03-31
Mariko Momoi BRD
 Director/Board Member 76 20-02-29

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 0 1,679,057,667 639,373,741 ( 38.08 %) 33,675,818 ( 2.006 %) 38.08 %

Shareholders

NameEquities%Valuation
ROCHE HOLDING AG
59.89 %
1,005,670,000 59.89 % 38 368 M ¥
CHUGAI PHARMACEUTICAL CO., LTD
2.012 %
33,788,400 2.012 % 1 289 M ¥
OrbiMed Advisors LLC
0.5408 %
9,079,800 0.5408 % 346 M ¥
Sumitomo Life Insurance Co.
0.5360 %
9,000,000 0.5360 % 343 M ¥
TOKIO MARINE HOLDINGS, INC.
0.3383 %
5,680,887 0.3383 % 217 M ¥
MFS International (UK) Ltd.
0.1962 %
3,294,600 0.1962 % 126 M ¥
Amundi Asset Management SA (Investment Management)
0.1601 %
2,688,322 0.1601 % 103 M ¥
Metzler Asset Management GmbH
0.1240 %
2,082,300 0.1240 % 79 M ¥
Sumitomo Mitsui Trust Asset Management Co., Ltd.
0.0749 %
1,258,200 0.0749 % 48 M ¥
Universal-Investment-Gesellschaft mbH (Invt Mgmt)
0.0689 %
1,156,844 0.0689 % 44 M ¥
NameEquities%Valuation
Todd Asset Management LLC
0.006545 %
219,780 0.006545 % 4 M ¥
Confluence Investment Management LLC
0.001153 %
38,730 0.001153 % 737 768 ¥
RhumbLine Advisers LP
0.000679 %
22,800 0.000679 % 434 317 ¥
PNC Investments LLC
0.000575 %
19,303 0.000575 % 367 703 ¥
Riverbridge Partners LLC
0.000393 %
13,200 0.000393 % 251 447 ¥
GAMMA Investing LLC
0.000189 %
6,337 0.000189 % 120 714 ¥
Tradition Wealth Management LLC
0.000040 %
1,345 0.000040 % 25 621 ¥
Operose Advisors LLC
0.000016 %
535 0.000016 % 10 191 ¥
Accent Capital Management LLC
0.000012 %
400 0.000012 % 7 620 ¥

Holdings

NameEquities%Valuation
CHUGAI PHARMACEUTICAL CO., LTD
2.01%
 33,788,400 2.01% 1,289,069,358 $
ONCOLYS BIOPHARMA INC.
2.25%
 456,600 2.25% 2,380,370 $

Company contact information

Chugai Pharmaceutical Co., Ltd.

Nihonbashi Mitsui Tower, 15/F 2-1-1 Nihonbashi-Muromachi

103-8324, Tokyo

+81 3 3281 6611

http://www.chugai-pharm.co.jp
address Chugai Pharmaceutical Co., Ltd(4519)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Ratings for Chugai Pharmaceutical Co., Ltd

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
4,860 JPY
Average target price
6,044 JPY
Spread / Average Target
+24.35%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
CHUGAI PHARMACEUTICAL CO., LTD Stock Chugai Pharmaceutical Co., Ltd
-9.02% 54.65B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+24.17% 562B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.44% 358B
MERCK & CO., INC. Stock Merck & Co., Inc.
+19.26% 322B
ABBVIE INC. Stock AbbVie Inc.
+8.21% 297B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.45% 219B
NOVARTIS AG Stock Novartis AG
+6.04% 199B
ROCHE HOLDING AG Stock Roche Holding AG
-10.51% 196B
PFIZER, INC. Stock Pfizer, Inc.
-11.67% 149B
AMGEN INC. Stock Amgen Inc.
-6.69% 146B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 4519 Stock
  4. Company Chugai Pharmaceutical Co., Ltd